BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2642109)

  • 1. The development of anti-glomerular basement membrane nephritis in two children with Alport's syndrome after renal transplantation: characterization of the antibody target.
    vd Heuvel LP; Schröder CH; Savage CO; Menzel D; Assmann KJ; Monnens LA; Veerkamp JH
    Pediatr Nephrol; 1989 Oct; 3(4):406-13. PubMed ID: 2642109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis.
    Pedchenko V; Bondar O; Fogo AB; Vanacore R; Voziyan P; Kitching AR; Wieslander J; Kashtan C; Borza DB; Neilson EG; Wilson CB; Hudson BG
    N Engl J Med; 2010 Jul; 363(4):343-54. PubMed ID: 20660402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-glomerular basement membrane antibody-mediated nephritis complicating transplantation in a patient with Alport's syndrome.
    Fleming SJ; Savage CO; McWilliam LJ; Pickering SJ; Ralston AJ; Johnson RW; Ackrill P
    Transplantation; 1988 Dec; 46(6):857-9. PubMed ID: 3061081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of two subsequent renal grafts by anti-GBM glomerulonephritis in Alport's syndrome: case report and review of the literature.
    Goldman M; Depierreux M; De Pauw L; Vereerstraeten P; Kinnaert P; Noël LH; Grünfeld JP; Toussaint C
    Transpl Int; 1990 Jul; 3(2):82-5. PubMed ID: 2206225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allograft rejection and glomerular basement membrane antibodies in Alport's syndrome.
    Charytan D; Torre A; Khurana M; Nicastri A; Stillman IE; Kalluri R
    J Nephrol; 2004; 17(3):431-5. PubMed ID: 15365966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Goodpasture antigen in Alport's syndrome: studies with a monoclonal antibody.
    Savage CO; Pusey CD; Kershaw MJ; Cashman SJ; Harrison P; Hartley B; Turner DR; Cameron JS; Evans DJ; Lockwood CM
    Kidney Int; 1986 Jul; 30(1):107-12. PubMed ID: 3528615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laminin, fibronectin, and Goodpasture antigen detection in patients with Alport's syndrome.
    Basta-Jovanovic G; Savin M; Jovanovic AZ; Veljovic R; Sindjic M
    Ren Fail; 1993; 15(4):503-8. PubMed ID: 8210562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-glomerular and anti-tubular basement membrane nephritis in a renal allograft recipient with Alport's syndrome.
    Diaz JI; Valenzuela R; Gephardt G; Novick A; Tubbs RR
    Arch Pathol Lab Med; 1994 Jul; 118(7):728-31. PubMed ID: 8024409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Goodpasture's disease and Alport's syndromes.
    Turner AN; Rees AJ
    Annu Rev Med; 1996; 47():377-86. PubMed ID: 8712789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gene corresponding to the putative Goodpasture antigen is present in Alport's syndrome.
    Savige JA
    Clin Exp Immunol; 1991 Aug; 85(2):236-9. PubMed ID: 1864003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single autoantigen in Goodpasture's syndrome identified by a monoclonal antibody to human glomerular basement membrane.
    Pusey CD; Dash A; Kershaw MJ; Morgan A; Reilly A; Rees AJ; Lockwood CM
    Lab Invest; 1987 Jan; 56(1):23-31. PubMed ID: 3540450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The non-collagenous domains of the alpha 3 and 4 chains of type IV collagen and their relationship to the Goodpasture antigen.
    Savige JA; Gallicchio M
    Clin Exp Immunol; 1991 Jun; 84(3):454-8. PubMed ID: 2044225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unusual case of pulmonary-renal syndrome associated with defects in type IV collagen composition and anti-glomerular basement membrane autoantibodies.
    Charytan D; MacDonald B; Sugimoto H; Pastan S; Staton G; Hennigar R; Kalluri R
    Am J Kidney Dis; 2005 Apr; 45(4):743-8. PubMed ID: 15806477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alport's syndrome: risk of glomerulonephritis induced by anti-glomerular-basement-membrane antibody after renal transplantation.
    Shah B; First MR; Mendoza NC; Clyne DH; Alexander JW; Weiss MA
    Nephron; 1988; 50(1):34-8. PubMed ID: 3050571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation.
    Brainwood D; Kashtan C; Gubler MC; Turner AN
    Kidney Int; 1998 Mar; 53(3):762-6. PubMed ID: 9507224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney transplantation in Alport's syndrome: long-term outcome and allograft anti-GBM nephritis.
    Göbel J; Olbricht CJ; Offner G; Helmchen U; Repp H; Koch KM; Frei U
    Clin Nephrol; 1992 Dec; 38(6):299-304. PubMed ID: 1468159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent allograft antiglomerular basement membrane glomerulonephritis in a patient with Alport's syndrome.
    Rassoul Z; al-Khader AA; al-Sulaiman M; Dhar JM; Coode P
    Am J Nephrol; 1990; 10(1):73-6. PubMed ID: 2188508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glomerulonephritis by glomerular anti-basement membrane antibodies after renal transplantation].
    Noel LH; Bobrie G; Pochet JM; Pirson Y; Goldman M; Moulonguet-Doleris L; Farge D; Déchelette E; Grunfeld JP
    Nephrologie; 1989; 10(3):113-5. PubMed ID: 2691906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary abnormalities of renal basement membranes.
    Savige J
    Pathology; 1991 Oct; 23(4):350-5. PubMed ID: 1686082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathogenesis of Alport syndrome involves type IV collagen molecules containing the alpha 3(IV) chain: evidence from anti-GBM nephritis after renal transplantation.
    Hudson BG; Kalluri R; Gunwar S; Weber M; Ballester F; Hudson JK; Noelken ME; Sarras M; Richardson WR; Saus J
    Kidney Int; 1992 Jul; 42(1):179-87. PubMed ID: 1635348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.